Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Using Magenetic Resonance Imaging to measure the hematocrit in fetal anemia
FY 2015-16
Summary
Fetal anemia is a pregnancy complication characterized by low hematocrit or hemoglobin levels in the fetus. Severe fetal anemia may lead to swelling and even death of the fetus. However, survival rates can exceed 90% if anemia is diagnosed early, monitored and treated with a series of procedures called intrauterine transfusions (IUTs) in a timely manner. The standard test to diagnose and monitor fetal anemia is middle cerebral artery (MCA) Doppler ultrasound. However, MCA Doppler has been proven unreliable in late pregnancy and after the first IUT treatment, giving rise to issues such as unnecessary IUT procedures, preterm delivery and increased risk of fetal death.This study investigates the clinical feasibility and accuracy of magnetic resonance imaging (MRI) as a novel alternative for diagnosing fetal anemia, by measuring hematocrit. Anemic fetuses have low hematocrits, meaning that they have fewer red blood cells. We will perform MRI scans on pregnant mothers in whom fetal anemia has been diagnosed with conventional methods. We will be able to calculate the fetus's hematocrit using certain MRI parameters. MRI hematocrit measurements will then be compared with accurate hematocrits obtained from laboratory fetal blood samples and MCA Doppler assessments. We expect MRI hematocrit determination to perform well in late pregnancy and for timing of subsequent IUTs. If so, MRI could become an additional way to diagnose anemia and monitor its treatment. This may be particularly useful in the later stages of pregnancy, when MCA Doppler is less reliable.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
350055
Name
Duan An Qi
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Using Magenetic Resonance Imaging to measure the hematocrit in fetal anemia
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Fetal Anemia; Fetal Hematocrit; Magnetic Resonance Imaging (Mri); Mca Doppler Ultrasound
Abstract
Fetal anemia is a pregnancy complication characterized by low hematocrit or hemoglobin levels in the fetus. Severe fetal anemia may lead to swelling and even death of the fetus. However, survival rates can exceed 90% if anemia is diagnosed early, monitored and treated with a series of procedures called intrauterine transfusions (IUTs) in a timely manner. The standard test to diagnose and monitor fetal anemia is middle cerebral artery (MCA) Doppler ultrasound. However, MCA Doppler has been proven unreliable in late pregnancy and after the first IUT treatment, giving rise to issues such as unnecessary IUT procedures, preterm delivery and increased risk of fetal death.This study investigates the clinical feasibility and accuracy of magnetic resonance imaging (MRI) as a novel alternative for diagnosing fetal anemia, by measuring hematocrit. Anemic fetuses have low hematocrits, meaning that they have fewer red blood cells. We will perform MRI scans on pregnant mothers in whom fetal anemia has been diagnosed with conventional methods. We will be able to calculate the fetus's hematocrit using certain MRI parameters. MRI hematocrit measurements will then be compared with accurate hematocrits obtained from laboratory fetal blood samples and MCA Doppler assessments. We expect MRI hematocrit determination to perform well in late pregnancy and for timing of subsequent IUTs. If so, MRI could become an additional way to diagnose anemia and monitor its treatment. This may be particularly useful in the later stages of pregnancy, when MCA Doppler is less reliable.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Duan, An Qi
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~